Helen M I Osborn (Helen Mi Osborn)

Years Active: 2017-2023
Publications (10 Years): 6

University of Cambridge

University of Bristol (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Cambridge Oct 01 1994 - Mar 31 1996

United Kingdom

PDRA :: Chemistry

Education History

University of Bristol Oct 01 1991 - Sep 30 1994

United Kingdom

PHD :: Chemistry

Publications

Madonna M A Mitry, Samuel Y Boateng, Francesca Greco, Helen M I Osborn
Bioorthogonal activation of prodrugs, for the potential treatment of breast cancer, using the Staudinger reaction. RSC medicinal chemistry 14 (8) (2023)
Madonna M A Mitry, Francesca Greco, Helen M I Osborn
In Vivo Applications of Bioorthogonal Reactions: Chemistry and Targeting Mechanisms. Chemistry (Weinheim an der Bergstrasse, Germany) (2023)
Mai Khater, John A Brazier, Francesca Greco, Helen M I Osborn
Anticancer evaluation of new organometallic ruthenium(ii) flavone complexes. RSC medicinal chemistry 14 (2) (2022)
Mai Khater, John A Brazier, Francesca Greco, Helen M I Osborn
Anticancer evaluation of new organometallic ruthenium(ii) flavone complexes. RSC medicinal chemistry 14 (2) (2022)
Jack Cheeseman, Gunter Kuhnle, Graham Stafford, Richard A Gardner, Daniel I R Spencer, Helen M I Osborn
Sialic acid as a potential biomarker for cardiovascular disease, diabetes and cancer. Biomarkers in medicine 15 (11) (2021)
Rebecca I Thomson, Richard A Gardner, Katja Strohfeldt, Daryl L Fernandes, Graham P Stafford, Daniel I R Spencer, Helen M I Osborn
Analysis of Three Epoetin Alpha Products by LC and LC-MS Indicates Differences in Glycosylation Critical Quality Attributes, Including Sialic Acid Content. Analytical chemistry 89 (12) (2017)

Helen M I Osborn.css-eqlu8i{font-size:small;padding-left:4px;} (Helen Mi Osborn)